Finland, Aug. 7 -- Finland based Fabentech SA has secured contract from Markkinaoikeus for Immune Sera and Immunoglobulins-Ristinitoxin Polyclonal Antibody. The value of the contract is worth 280900000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....